Figure 6.
Figure 6. Inhibition of elastase reduces AML-cell proliferation while maintaining normal undifferentiated CD34+ cells. (A) AML cell lines (U937 and ML-2), primary AML cells, and CB CD34+ cells were cultured for 3 to 7 days with or without EI (10 μg/mL), and the number of viable cells was determined using trypan blue exclusion. Results are shown as percentage of viable cells compared with CTL-untreated cells plotted as 100%; *P ≤ .005. (B) CB CD34+ cells were cultured for 3 days with or without EI (10 μg/mL). The percentage of CD34+/CD38- cells was determined by flow cytometry. Results are mean ± SE of 4 independent experiments; *P ≤ .05.

Inhibition of elastase reduces AML-cell proliferation while maintaining normal undifferentiated CD34+cells. (A) AML cell lines (U937 and ML-2), primary AML cells, and CB CD34+ cells were cultured for 3 to 7 days with or without EI (10 μg/mL), and the number of viable cells was determined using trypan blue exclusion. Results are shown as percentage of viable cells compared with CTL-untreated cells plotted as 100%; *P ≤ .005. (B) CB CD34+ cells were cultured for 3 days with or without EI (10 μg/mL). The percentage of CD34+/CD38- cells was determined by flow cytometry. Results are mean ± SE of 4 independent experiments; *P ≤ .05.

Close Modal

or Create an Account

Close Modal
Close Modal